Journal of Bacteriology, June 2001, p. 3652-3662, Vol. 183, No. 12
0021-9193/01/$04.00+0 DOI: 10.1128/JB.183.12.3652-3662.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.

Department of Microbiology, University of Texas Health Science Center, San Antonio, Texas 78229-3900
Received 2 February 2001/Accepted 30 March 2001
| |
ABSTRACT |
|---|
|
|
|---|
ToxR, the transmembrane regulatory protein required for expression
of virulence factors in the human diarrheal pathogen Vibrio cholerae, directly activates and represses the transcription of two outer membrane porins, OmpU and OmpT, respectively. In an attempt
to dissect the role of the OmpU and OmpT porins in viability and
virulence factor expression, in-frame chromosomal deletions were
constructed in the coding sequences of ompU and
ompT of V. cholerae. Two separate deletions
were introduced into ompU; the first (small) deletion,
ompU1, removed the coding sequence for 84 internal amino
acids (aa), while the second (large) deletion,
ompU2,
removed the coding sequence for the entire amino-terminal 274 aa. The
ompU1 strain had a growth defect that could not be complemented by episomal expression of full-length ompU. In
contrast, a strain with
ompU2 displayed wild-type growth
kinetics in rich media, suggesting that this is the true phenotype of a
strain lacking OmpU and that the truncated OmpU protein, rather than the absence of OmpU, may be the cause for the
ompU1
phenotype. A large deletion removing the coding sequence for the entire
N-terminal 273 aa of OmpT (
ompT) was also constructed in
wild-type as well as
toxR and
ompU2
strains, and these strains displayed wild-type growth kinetics in rich
media. However, the
ompU2 strain was deficient for
growth in deoxycholate compared to wild-type,
ompT, and
ompU2
ompT strains, reinforcing a
positive role for the OmpU porin and a negative role for the OmpT porin
in V. cholerae resistance to anionic detergents. The
ompU2,
ompT, and
ompU2
ompT strains exhibited wild-type levels of in vitro
virulence factor expression and resistance to polymyxin B and serum and in vivo colonization levels similar to a wild-type strain in the infant
mouse intestine. Our results demonstrate that (i) OmpU and OmpT are not
essential proteins, as was previously thought; (ii) these porins
contribute to V. cholerae resistance to anionic detergents;
and (iii) OmpU and OmpT are not essential for virulence factor
expression in vitro or intestinal colonization in vivo.
| |
INTRODUCTION |
|---|
|
|
|---|
Vibrio cholerae, a motile gram-negative bacterium, lives primarily in aquatic environments. Upon entry into a human host, V. cholerae can cause the devastating and potentially lethal form of diarrhea known as cholera. The pathogens synthesize virulence factors, including cholera toxin (CT) and toxin coregulated pilus (TCP), in the small intestine, presumably in response to yet-undefined environmental signals (for a review, see reference 48). ToxR, a transmembrane transcriptional activator, initiates these events in association with TcpP, a second transmembrane transcriptional activator, by stimulating the transcription of toxT (13, 18, 20, 26). The ToxT protein directly activates transcription of the ctx and tcp genes, which encode CT and TCP (14). This virulence cascade can be induced in vitro by specific growth conditions (13). The ctx, tcp, and toxT genes are located on mobile genetic elements associated primarily with epidemic V. cholerae (21, 25, 41, 56), while the toxR gene is found in the ancestral Vibrio genome (23, 40, 58), suggesting that ToxR has recently been recruited into this virulence cascade.
The ancestral role of ToxR appears to be as a modulator of outer membrane (OM) porins, because ToxR, independently of TcpP and ToxT, activates and represses transcription of two genes encoding major OM porins, OmpU and OmpT, respectively (8, 31). This regulation results in virtually exclusive expression (in vitro) of OmpU in wild-type (toxR+) strains, while toxR mutant strains express OmpT exclusively. However, even though ompU is transcribed at relatively high levels in toxR+ strains, certain laboratory conditions (e.g., the addition of bile) can stimulate increased levels of ToxR-dependent ompU transcription, indicating that ToxR transcriptional activity is modulated by environmental signals (43). ToxR also regulates expression of OM proteins, potentially porins, in other Vibrio and/or Photobacterium species, including V. parahaemolyticus, V. fluvialis, V. mimicus, and Photobacterium profundum (23, 43, 58).
OM porins of gram-negative bacteria, such as OmpU and OmpT, function
primarily as channels for entry and exit of hydrophilic, low-molecular-weight molecules. Porins form hydrophilic channels composed of trimeric
-barrels with pore sizes ranging from 1 to 2 nm
in diameter (for a review, see reference 37). The porin channels are small enough to prevent large molecules, including hydrolytic enzymes and binding proteins, from leaving the periplasmic space. Diffusion rates across porins are near maximal for small molecules; however, solute-discriminating properties are based on the
amino acid residues that protrude toward the lumen of the porin channel
(10). For example, PhoE of Escherichia coli is preferentially permeable toward anions, while OmpF and OmpC show preference toward cations (5). Porins are important
constituents of the OM, comprising up to 2% of the entire protein
content of the cell (38).
Up to 10 major OM proteins have been identified in V. cholerae (22). Porin activity has been demonstrated for OmpU, OmpT (4, 7), and OmpS, a 43-kDa maltoporin sharing homology with LamB of E. coli (27). Liposome swelling assays predicted a pore size of 1.6 nm for OmpU trimers, while that of OmpT trimers was smaller but not quantitated (7). V. cholerae also has an OmpA homologue (2), as well as the highly immunogenic proteins OmpV, OmpW, and OmpX (12, 51); no known biological function has been demonstrated for these OM proteins. However, porin activity is reportedly absent for OmpV (4) and OmpX (7). It is probable that additional porin activities will be identified in the OM of V. cholerae; at least one additional putative porin (VC0972) was identified within the recently sequenced V. cholerae genome (19). Correct insertion of the OmpU and OmpT porins into the OM requires the type II extracellular protein secretion (EPS) pathway, which is also required for secretion of CT (47).
Porins of gram-negative organisms have been surmised to play roles in the pathogenesis of Neisseria meningitidis (33), Shigella flexneri (6), and Salmonella enterica serovar Typhimurium (35). The OmpC porin of E. coli and serovar Typhimurium is less permeable to bile (and therefore more protective) than OmpF (54). Nikaido (37) hypothesized that enteric pathogens express OmpC in the mammalian host to reduce permeability toward anionic detergents in the high-osmolarity conditions within the intestine, while still permitting permeability of smaller nutrients such as glucose. The OmpF porin, expressed in growth conditions of low osmolarity, is speculated to be beneficial when the bacteria are outside the host in nutrient-poor, aqueous environments.
Understanding the role of the ToxR-regulated OmpU and OmpT porins in V. cholerae pathogenesis has been hindered by difficulties encountered in the construction of V. cholerae strains with mutations in ompU and ompT, leading to the hypothesis that these are essential genes (28, 49). An initial report utilizing a tissue culture model suggested that OmpU acts as an adhesin (50), but this finding has remained unconfirmed (34, 42). We have presented evidence that ToxR mediates increased resistance to anionic detergents in enteropathogenic Vibrio species and that this enhanced resistance correlated with increased OmpU expression in V. cholerae (43). Recently, we succeeded in demonstrating a direct role for OmpU and OmpT in relative resistance to bile by reversing the ToxR-dependent modulation of these porins (i.e., expressing OmpT in place of OmpU in a toxR+ strain and expressing OmpU in place of OmpT in a toxR mutant strain). Our results demonstrated that V. cholerae expressing OmpT is less resistant to anionic detergents than V. cholerae expressing OmpU. Moreover, a strain expressing OmpT in place of OmpU shows significantly reduced virulence factor expression in vitro and intestinal colonization in vivo (42). These results suggest a role for OmpU and OmpT not only in bile resistance but also in the signal transduction cascade that leads to virulence factor expression and intestinal colonization.
In the present study we investigated the phenotype(s) of V. cholerae strains lacking OmpU and/or OmpT. Our results demonstrate that ompU and ompT are not essential genes of V. cholerae, although the design of the gene disruption is important to eliminate any negative effects associated with expression of the remaining porin coding sequence. V. cholerae lacking OmpU was more sensitive to anionic detergents than a wild-type strain, corroborating a protective role for OmpU in bile resistance. V. cholerae strains lacking OmpU, OmpT, or both resembled wild-type strains with respect to virulence factor expression in vitro and intestinal colonization in vivo, indicating that neither OmpU nor OmpT is required for these pathogenic properties.
| |
MATERIALS AND METHODS |
|---|
|
|
|---|
Growth conditions and media. All experiments, except where noted, were performed with classical V. cholerae 0395 grown in Luria broth (LB) supplemented with appropriate antibiotics. Inducing conditions for expression of virulence factors were growth in LB at pH 6.5 at 30°C, and noninducing conditions were growth in LB at pH 8.5 at 30°C. Growth rate experiments with LB supplemented with deoxycholate (DOC; Sigma) were performed at 37°C as described previously (43). Growth experiments in minimal medium were performed at 37°C in M9 medium utilizing glucose (0.2%) as the sole carbon source (55). Resistance to polymyxin B was determined utilizing cultures grown overnight at 37°C in Mueller-Hinton broth (MHB) as described previously (39).
Plasmid construction.
Oligonucleotides used in the
construction of the porin deletions are listed in Table
1. Primers contain restriction sites (underlined in Table 1) utilized in cloning. The
ompU1
deletion construct was generated by PCR amplification of the 3' end of ompU (11) with primers OMPU2XBI and OMPU1BHI.
The resulting 521-bp fragment was digested with XbaI and
BamHI and ligated into pWKS30 (57) that had
been similarly digested to yield pKEK188. Then, a 5' sequence of
ompU was PCR amplified with primers OMPUP1ERI and
OMPUP2BGLII, which resulted in a fragment of 847 bp
containing the entire ompU promoter and also the first 24 bp
of the coding sequence. This fragment was digested with
BglII and EcoRI and ligated into pKEK188 that had
been digested with the same restriction enzymes, yielding pKEK189. This
ompU1 in-frame deletion removes the coding sequence for
aa 9 to 90 of the nascent OmpU protein (i.e., including the leader
peptide). The entire
ompU1 construct from pKEK189 was
digested with SalI and NotI and then ligated into
pKEK229 (9), a derivative of pCVD442 (15),
yielding pKEK235, which was used to recombine the mutation into the
V. cholerae chromosome.
|
ompU2 deletion was constructed in several steps.
First, the promoter region of ompU was amplified by PCR with
primers OMPUPERI and OMPUP2NDEI, and the
resulting 828-bp fragment was digested with BamHI and
EcoRI, and ligated into pWKS30 digested similarly, to yield
pKEK242. A fragment containing the 3' end of ompU was PCR
amplified utilizing primers OMPUDEL1 and OMPUDEL2, and the resulting 476-bp fragment was digested with
NdeI and SacII and ligated into pKEK242 that had
been similarly digested to yield pKEK252. This
ompU2
in-frame deletion removes the coding sequence for aa 1 to 273 of OmpU,
leaving only the final 68 aa of the protein. The entire
ompU2 construct from pKEK252 was then digested with SacI and XhoI and ligated into pKEK229
(9), digested similarly, to form pKEK276, which was used
to recombine the mutation onto the V. cholerae chromosome.
The
ompT deletion was obtained by first PCR amplifying
the ompT promoter, using primers OMPTP1HDIII and
OMPTP2NDEI, digesting the resulting 528-bp fragment with
HindIII and BamHI, and then ligating it with
pWKS30 digested similarly, to yield pKEK243. Next, the 3' end of
ompT was PCR amplified with primers OMPTCTERM1 and OMPTCTERM2, and the resulting 490-bp fragment was
digested with NdeI and BamHI and ligated with
pKEK243 digested similarly, yielding pKEK306. This
ompT
in-frame deletion removes the coding sequence for aa 1 to 273 of OmpT,
leaving only the final 71 aa of the protein. The entire
ompT construct from pKEK306 was then digested with
NotI and XhoI and ligated with pKEK229
(9), digested similarly, yielding pKEK309, which was used
to recombine the mutation onto the V. cholerae chromosome.
Plasmids expressing ompU and ompT from their
natural promoters were constructed in the following manner. The entire
coding sequence of ompU was PCR amplified using primers
OMPU1NDEI and OMPU2SACII. The resulting 1,026-bp
fragment was then digested with NdeI and SacII
and ligated into pKEK242 digested similarly, yielding PKEK253. Because
the NdeI site engineered into the primers is incorporated
into the initiating methionine of the OmpU coding sequence, this
plasmid reconstructs ompU downstream of its natural ompU promoter. The entire ompT coding sequence
was PCR amplified with primers OMPTINDEI and
OMPT2SACII, and the resulting 1,035-bp fragment was digested
with NdeI and SacII and ligated into pKEK243, similarly digested, to yield pKEK255. As with the ompU
plasmid, this plasmid reconstructs ompT downstream of its
natural ompT promoter.
Plasmids pAA35 and pAA48, which were used to construct
epsD::Kan and
epsE::Kan
V. cholerae strains, were kindly provided by S. Sozhamannan
(1). Plasmid pJS752-3 (46), used to express CT-B for secretion experiments, was a considerate gift of C. Lopez Macias.
Bacterial strains.
Bacterial strains utilized in this study
are listed in Table 1. Escherichia coli strain
SM10
pir (31) was employed to transfer deletion constructs into the V. cholerae chromosome by
conjugation, while strain DH5
(17) was utilized for all
cloning experiments. All V. cholerae strains are isogenic
with the classical Ogawa strain O395 (30). V. cholerae strains KKV61 (
toxR) (24) and KKV598 (
lacZ) (16) have been described previously.
ompU1), KKV780 (
ompU2),
KKV809 (
ompT), KKV1234
(
epsE::Kan), KKV804 (
toxR
ompT), KKV884 (
ompU2
ompT),
KKV1216 (
epsD::Kan), and KKV1232
(
epsE::Kan
ompU2). Chromosomal
mutations were confirmed by PCR with specific primers. The deletion
strains were further verified by SDS-PAGE and Western blots probed with
either
-OmpU or
-OmpT antisera.
Detection of protein expression.
The isolation of OM
proteins from V. cholerae was accomplished using the method
of Miller and Mekalanos (31). Whole-cell lysates or OM
preparations were separated by sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) on a 10% polyacrylamide gel and stained
with Coomassie brilliant blue for visualization. Protein gels were
transferred to nitrocellulose for Western blotting using a transblotter
(Bio-Rad). The blots were probed with rabbit polyclonal antisera
against V. cholerae OmpU, OmpT, and outer membrane proteins (OMPs) (12) (the kind gift of J. Peterson) and developed
utilizing the ECL Detection System (Amersham). Culture supernatants
were assayed for CT by GM1-enzyme-linked immunosorbent
assay (ELISA) with rabbit polyclonal antiserum against the purified B
subunit of CT (53). Intracellular CT was determined
similarly from V. cholerae strains carrying plasmid pJS752-3
(46) grown in LB overnight. One milliliter of culture was
centrifuged, and the pellet was resuspended in sonication buffer (10 mM
Tris-HCl, 1 mM EDTA, 20% glucose), sonicated twice for 15 s, and
then assayed for CT-B. TCP expression was determined by transduction
with CTX
-Cm as described previously (56). The CTX
-Cm
was constructed by replacing the kanamycin cassette in CTX
-Kan
(kindly provided by M. Waldor) with the Cmr gene from
pACYC184 (44). OM integrity was measured using a periplasmic leakage assay, which was determined by Western blots of
supernatants from overnight grown cultures carrying plasmid pBR322
(32) with antiserum to
-lactamase (5Prime-3Prime,
Inc.).
Resistance to serum and polymyxin B. For serum resistance assays, overnight cultures (~107 bacteria) were added to a final concentration of 20% normal human serum (NHS) or 20% heat-inactivated NHS in phosphate-buffered saline (PBS) with 0.1% peptone and incubated for 1 h at 37°C (36). Serum resistance was determined by quantitating the CFU in both NHS and heat-inactivated NHS. MIC determinations for polymyxin B were carried out with bacteria grown overnight at 37°C in MHB as described elsewhere (36).
In vivo colonization assay.
Mixtures of wild-type strain
KKV598 (O395
lacZ) with either KKV780
(
ompU2), KKV809 (
ompT), or KKV884
(
ompU2
ompT) were coinoculated into
5-day-old CD-1 suckling mice in a peroral inoculum ratio of
approximately 105 mutant to 105 wild-type
organisms. After 22 h of colonization, the isolated small intestines
were homogenized, and the mutant/wild-type ratio was determined by
plating dilutions on LB agar containing X-Gal (5-bromo-4-chloro-3-indolyl-
-D-galactopyranoside). In
vitro competition was caried out in 5 ml of LB inoculated with the same
mixtures and grown at 37°C overnight.
| |
RESULTS |
|---|
|
|
|---|
Construction of viable
ompU V. cholerae
strains.
Our initial strategy to generate mutations in both porin
genes ompU and ompT involved generating the
deletions in V. cholerae carrying an additional episomal
copy of the porin gene because it had been suggested that these genes
are essential for the viability of V. cholerae (28,
49). With this strategy, the porin gene carried on the plasmid
would complement a lethal deletion introduced into the porin gene in
the chromosome, allowing for viability in an otherwise nonviable
strain. This strategy was used to construct a V. cholerae
strain with a small (252-bp) in-frame internal chromosomal deletion
within the ompU gene (
ompU1). This strain
(KKV669) was then cured of the episomal copy of ompU and, to
our surprise, was viable, although it formed colonies distinctly
smaller than those of the wild type on LB agar (data not shown). These
results demonstrate that a deletion of ompU does not convey
a lethal phenotype to V. cholerae.
ompU1
strain, as determined by Western blots probed with OmpU antiserum (Fig.
1A and C, lane 2, compared to wild-type
OM, lane 1). The
ompU1 strain demonstrates a growth
defect in minimal M9 medium compared to the isogenic wild-type strain
(Fig. 2). Noticeably, complementation of
ompU1 with the wild-type ompU gene on a
plasmid, which restores detectable full-length OmpU to the outer
membrane (Fig. 1C, lane 3), did not fully restore the defective growth phenotype of the
ompU1 strain (Fig. 2), suggesting a
dominant-negative phenotype associated with the deleted gene. In fact,
ompU1 carried on a plasmid (pKEK344) confers a
slow-growth phenotype to a wild-type strain (Fig. 2), a result
consistent with a negative effect of the internally deleted OmpU
polypeptide on cell growth. The predicted
ompU1 product
has a truncated signal peptide of 8 aa fused to the remaining 249 aa of
the protein, which is likely not secreted into the periplasm. Although
we cannot detect the internally deleted
ompU1 polypeptide
by Western blot even from whole-cell lysates (data not shown), retarded
growth kinetics suggest its presence within the cell. The presence of
OmpU polypeptide that has not been incorporated into the OM is
predicted to be one of the causes of the slow-growth phenotype of
strains with mutations in the EPS pathway (47; see also
below).
|
|
ompU1 strain appears to have a negative effect on growth,
we designed a larger in-frame deletion of ompU which removes
the entire coding sequence for the amino-terminal 274 aa, leaving only
the coding sequence for 67 aa of the C terminus (
ompU2).
Because we knew that a deletion of ompU was not a lethal
mutation, the introduction of the
ompU2 mutation into the
V. cholerae chromosome was carried out in strains without an
episomal copy of the wild-type ompU gene.
Importantly, the resulting
ompU2 V. cholerae strain
KKV780 formed colonies the same size as those formed by the wild type on LB agar (data not shown). OmpU could not be detected in OM fractions
of this strain, as determined by Western blot utilizing OmpU antiserum
(Fig. 1A and C, lane 4), and the introduction of wild-type
ompU on a plasmid to the
ompU2 strain restores
OmpU expression (Fig. 1A and C, lane 5). The
ompU2 strain
grew identical to the wild type in minimal M9 medium (Fig. 2).
Introduction of a plasmid containing
ompU2 had no
deleterious effect on the growth of a wild-type strain (data not
shown), indicating that, unlike the
ompU1 polypeptide, no
dominant-negative phenotype is associated with the
ompU2
polypeptide. Thus, the
ompU2 strain more accurately represents the true phenotype of a strain lacking OmpU. Our results suggest that the design of the mutation in ompU is critical
to obtaining the desired mutant V. cholerae strain, perhaps
explaining previous difficulties in obtaining these mutations
(28, 49)
Construction of viable
ompT and
ompU
ompT V. cholerae strains.
Under laboratory
conditions, toxR wild-type V. cholerae expresses
almost exclusively OmpU and very little OmpT, while toxR mutant V. cholerae expresses OmpT exclusively. This is
caused by ToxR-dependent activation of the ompU promoter and
ToxR repression of the ompT promoter (11, 28).
A large in-frame deletion of ompT (
ompT),
which removes the coding sequence for the first 273 aa, leaving only
the C-terminal 71 aa, was recombined onto the chromosomes of both
wild-type (toxR+) and
toxR V. cholerae strains, resulting in strains KKV809 (
ompT) and KKV804 (
toxR
ompT). In contrast to a
toxR strain, the
toxR
ompT
strain had no detectable OmpT in its OM, as determined by Western blot
probed with OmpT antiserum (Fig. 1A and B, compare lanes 8 and 9). The
introduction of a wild-type copy of ompT onto a plasmid to
the
toxR
ompT strain restores OmpT
expression (Fig. 1A and B, lane 10). Both
ompT and
toxR
ompT strains have growth rates
indistinguishable from that of a wild-type strain in minimal M9 medium
(Fig. 2), demonstrating that OmpT is not essential for viability in
either toxR+ or toxR mutant V. cholerae.
ompT mutation was introduced into the
chromosome of the
ompU2 strain KKV780, resulting in
strain KKV884 (
ompU2
ompT). There was no
detectable OmpU protein in the OM of this strain (Fig. 1A and C,
compare lanes 1 and 6). In concentrated OM preparations, OmpT can be
detected with specific antiserum in a wild-type
(toxR+) strain (Fig. 1B, lane 1), but no OmpT
was detected in the OM of the
ompU2
ompT
strain (Fig. 1B, lane 6). This double-mutant strain grew almost
identically to the wild type in M9 minimal medium (Fig. 2). Evidently,
both ToxR-modulated porin genes can be deleted within the same strain
without a loss of viability.
Additional OM proteins are present in
ompU and
ompT OM.
Porins allow nutrients and other solutes
to pass through the OM, and thus the loss of major OM porin(s) may
induce compensatory expression of alternate porins to maintain both OM
structure and permeability. In OM preparations of several V. cholerae porin deletion strains, expression of alternate OM
proteins could be observed (Fig. 1A). A protein band migrating at ~35
kDa (the known migration rate of OmpA [2]) was
noticeably overexpressed in the strains lacking both OmpU and OmpT in
their OM,
ompU2
ompT and
toxR
ompT (lanes 6 and 9). This band was not visible in the
same strains complemented with either OmpU- or OmpT-expressing plasmids
(lanes 7 and 10). Western blot analysis utilizing antiserum directed
against V. cholerae OM proteins (12) (Fig. 1D)
revealed that the ~35-kDa OM protein induced prominently in the
toxR
ompT strain is probably not the same
OM protein induced in the
ompU2
ompT strain
(compare Fig. 1A and D, lanes 6 and 9). These results suggest that two
separate proteins migrating at ~35 kDa are overexpressed in the OMs
of
ompU
ompT and
toxR
ompT strains.
Growth defect of epsE mutant is suppressed by
ompU2 mutation.
The type II EPS machinery of
V. cholerae recognizes proteins in the periplasm targeted
for secretion or insertion in the OM (e.g., CT and OmpU or OmpT) and
translocates them to their destination (for a review, see reference
45). Recent reports have suggested that a lack of OmpU and
OmpT in the OM contribute to the growth defect observed in V. cholerae eps mutant strains (29, 47). Sandkvist and
colleagues (47) showed decreased OmpU and OmpT in the OM
of eps strains and speculated that a decrease of these two
porins in the OM may correlate with the observed growth defect. However, our results demonstrate that a lack of OmpU or OmpT in the OM
per se does not cause a growth defect (
ompU2 and
toxR
ompT) (Fig. 2), but the growth defect
caused by the dominant-negative
ompU1 allele suggests
that OmpU protein that fails to be inserted in the OM may retard
growth. To test whether OmpU plays a role in the growth defect reported
for an epsE strain, we generated a double-mutant
epsE
ompU2 strain and compared its growth
rate in LB to isogenic
epsE and
ompU2
strains (Fig. 3A). As had been noted
before (47), an
epsE mutant strain displays
a severe growth defect, while a
ompU2 mutant strain has a
growth rate similar to that of the wild type and the
ompU2
ompT strains. The
ompU1
strain displays a slight growth defect in this rich medium, although
not as severe as was previously shown in minimal medium (Fig. 2).
Interestingly, the introduction of the
ompU2 mutation
into the
epsE strain (
epsE
ompU2) greatly ameliorated the growth defect conferred by
the
epsE mutation. These results are consistent with the
hypothesis that the presence of OmpU that is not inserted into the OM
contributes (at least in part) to the growth defect of eps
strains.
|
epsE, and
epsE
ompU2 strains (Fig. 3B and C)
revealed that very little OmpU could be detected by Western blot with
OmpU antiserum in the OM of the
epsE strain (lane 2, compared to the wild type in lane 1), as described previously
(47). The OM of the
epsE
ompU2
strain (lane 3) contains no OmpU, as anticipated (Fig. 3C), but showed the presence of OM proteins absent in the
epsE strain.
Most noticeable is a prominent ~43-kDa band evident in the OM profile
of
epsE
ompU2 that may represent the
maltoporin OmpS (27). Also, a Western blot probed with
antiserum against V. cholerae OM proteins revealed an
~28-kDa band in the
epsE
ompU2 strain
(Fig. 3D, lane 3) that is absent in the
epsE strain (lane
2) but present at lower levels in the wild-type strain (lane 1).
Interestingly, the same antiserum revealed the presence of an ~35-kDa
OMP in the
epsE
ompU2 strain that is absent
in the OM of both the
eps and wild-type strains. Thus,
the removal of OmpU from the epsE strain allows for the
expression and/or insertion of alternate proteins into the OM, which
may in turn permit a faster growth rate.
Effect of ompU and ompT deletions on
virulence factor expression.
Our previous studies have shown that
a ToxR+ strain expressing OmpT in place of OmpU has reduced
levels of CT secretion and TCP expression in vitro (42),
indicating that the presence of OmpT has a negative effect on the
V. cholerae virulence regulatory cascade. To determine if
the absence (rather than the presence) of OmpU and/or OmpT affects in
vitro virulence factor expression, the various ompU and
ompT mutant strains were measured for CT and TCP expression
under laboratory inducing conditions. CT secreted into the supernatant
was measured by GM1-ELISA assay, while TCP expression was
measured both by autoagglutination (a function of TCP expression) and
CTX
transduction frequency (CTX
utilizes TCP as its receptor
[56]). The
ompU2 and
ompT
strains, as well as the
ompU2
ompT
double-mutant strain, secreted CT and expressed TCP similar to a
wild-type strain (Table 2), indicating that neither porin is required for CT and TCP expression in vitro. Interestingly, the
ompU1 strain showed an ~30-fold
decrease in CT secretion compared to wild type, which was accompanied
by lack of autoagglutination and a decrease in TCP production as
determined by CTX
-Cm transduction. Because the
ompU2
mutant had no defect in CT and TCP expression, the defect in virulence
factor expression of the
ompU1 strain must be due to the
dominant-negative phenotype associated with the truncated OmpU
polypeptide rather than the lack of OmpU. As expected, the
toxR
ompT strain produced no virulence
factors in vitro, due to lack of ToxR, as is seen with a strain
containing the
toxR mutation alone (Table 2). None of the
porin-deficient strains exhibited virulence factor expression under
noninducing, control growth conditions at pH 8.5 and 30°C.
|
ompU1 shares a slow-growth
phenotype with eps mutants that may depend on the inability
to insert OmpU in the OM, we sought to determine if the observed defect
in secreted CT by the
ompU1 strain is related to a defect
in CT secretion (vs. CT expression). Strains were transformed with
plasmid pJS752-3 (46), which expresses CT-B subunit and
then assayed for CT-B present in cell lysates compared to culture
supernatants. The
ompU1 strain retained little
intracellular CT-B (2.9%), compared to either epsE or
epsD strains, which retained much higher levels of
intracellular CT-B (74.9 and 70.5%, respectively). These results suggest that the lower levels of secreted CT by the
ompU1
strain are not due to a gross defect in protein secretion. As expected, none of the other V. cholerae strains with deletions in
ompU and ompT demonstrated defects in CT-B secretion.
Effect of ompU and ompT deletions on
resistance to antimicrobial substances.
Next, we tested whether
removal of major OM porins can affect the integrity of the OM in
V. cholerae, leading to altered permeability or sensitivity
to antimicrobial agents acting on the cell surface. To identify any OM
defects associated with the lack of OmpU and/or OmpT, we assayed the
ompU and
ompT strains for sensitivity to polymyxin B, a polycationic agent that disrupts the OM, and to NHS. The
MICs for polymyxin B were similar for all strains (Table 2). Likewise,
serum resistance was largely unaffected by the lack of OmpU or OmpT in
the OM. These results suggest that the absence of OmpU and OmpT does
not substantially affect V. cholerae sensitivity to these
antimicrobial agents.
-lactamase, which is normally localized in the periplasm
(32). We transformed the porin-deficient strains with
pBR322 (52) and examined cell-free supernatants by Western blot with antiserum to
-lactamase (36). No significant
differences were found in the amount of
-lactamase from the
supernatants of the porin deletion strains (data not shown).
Additionally, visualization of the lipopolysaccharide (LPS) of the
various strains in silver-stained gels did not reveal any obvious
structural defects (Jutta Nesper, personal communication). These
results show that the absence of the V. cholerae
ToxR-modulated porins does not adversely affect OM integrity or LPS structure.
Roles for OmpU and OmpT in resistance to DOC.
We previously
demonstrated that a ToxR+ strain that expresses OmpT in
place of OmpU has decreased levels of resistance to DOC, suggesting
that OmpU-containing cells are more resistant and that OmpT-containing
cells are more sensitive to anionic detergents (42). In
order to determine if strains lacking OmpU and/or OmpT have altered
levels of resistance to DOC, we tested the
ompU2,
ompT, and
ompU2
ompT strains
for relative growth rates in DOC. The
ompU2 strain
displays retarded growth kinetics over a wide DOC concentration range
in comparison to wild-type,
ompT, and
ompU2
ompT strains (Fig. 4),
corroborating a protective role for OmpU in V. cholerae bile
resistance. Interestingly, the introduction of the
ompT
mutation into the
ompU2 strain (
ompU2
ompT double mutant) increased the level of relative DOC
resistance. Also, the single-mutant
ompT strain had
growth kinetics comparable to those of the wild type at lower DOC
concentrations, but it consistently grew even better than the wild type
at higher concentrations (0.5% DOC). These results are consistent with
OmpT playing a negative role in bile resistance.
|
Colonization of the infant mouse small intestine.
A
ToxR+ strain that expresses OmpT in place of OmpU is
defective for colonization of the infant mouse small intestine,
demonstrating that the presence of the ToxR-repressed porin can inhibit
V. cholerae virulence (42). To determine if the
absence, rather than the presence, of OmpU and/or OmpT affects
colonization of the suckling mouse small intestine, in vivo competition
experiments were performed with the
ompU2,
ompT, and
ompU2
ompT strains
(Fig. 5). The competitive indices for
ompU2 and
ompU2
ompT strains
were similar, if slightly less than those for the wild type (0.32 ± 0.16 and 0.40 ± 0.23, respectively), while that of the
ompT strain was slightly better than that of the wild
type (2.57 ± 1.86). The same trend was seen in an in vitro
competition with these strains (
ompU2, 0.56;
ompT, 1.20;
ompU2
ompT,
0.36), suggesting that the mild defects or advantages of these strains
for colonization in vivo are due to competitive growth differences.
Thus, the ToxR-regulated porins OmpU and OmpT are not essential for
colonization of the infant mouse small intestine, indicating that OmpU
most probably plays no role in adherence in vivo.
|
| |
DISCUSSION |
|---|
|
|
|---|
The results of our study underscore the importance of the design
of the ompU mutation in obtaining cells that reflect the true phenotype of a strain lacking OmpU without additional adverse phenotypes. We constructed two different in-frame deletions in the
ompU gene, and strains containing these mutations had very different phenotypes. The
ompU1 V. cholerae strain has a
small in-frame deletion (84 aa) and displayed a considerable growth defect. This phenotype is dominant negative, because
ompU1 can confer a slow-growth phenotype on a wild-type
(ompU+) strain in trans. In contrast,
a strain containing a large in-frame deletion (274 aa),
ompU2, which removes the majority of the coding sequence
at the amino terminus, grows like a wild-type strain in both minimal
and rich media.
We suspect that the slow-growth phenotype associated with the
ompU1 mutation is caused by the internally deleted OmpU
polypeptide, although truncated peptide could not be detected by OmpU
antisera. Because the
ompU1 mutation removes 13 aa of the
21-aa leader peptide, the resultant OmpU polypeptide is likely not
secreted into the periplasm, thus suggesting that it exerts its effect from within the cytoplasm. The
ompU2 mutation was
designed to remove the entire leader peptide, as well as the majority
of the coding sequence for the mature protein, and this deletion
eliminated the negative effects on growth seen with
ompU1. Therefore, it is reasonable to conclude that the
ompU2 strain represents the true phenotype of a V. cholerae strain lacking OmpU. Likewise, the
ompT
mutation, which removed the majority of the amino terminus of OmpT,
does not cause any growth defect in toxR+ or
toxR mutant strains in either minimal or rich medium, and therefore this mutation truly represents an ompT null
mutation. Other researchers have reported difficulty in the disruption
of ompU or ompT (28, 49), which had
led to the hypothesis that these genes are essential for V. cholerae viability. We suggest that the design of the
ompU or ompT mutations attempted could have led
to a slow-growth phenotype which made it difficult to isolate these
mutant strains.
Porins constitute a major portion of the OM proteins, and it has been
estimated that OmpU represents ca. 30 to 60% of the total OMPs of
V. cholerae (7). Given the functional as well as the likely structural roles of OmpU, it is perhaps not surprising to
find at least one alternate OM protein expressed in its absence. An OM
protein migrating at 28 kDa was consistently overexpressed in strains
without OmpU, regardless of the presence or absence of ToxR or OmpT.
The relative migration rate of this protein approximates the reported
size for OmpX, a 29-kDa OMP that was reported not to have porin
activity (7). Likewise, OM proteins migrating at 35 kDa
were overexpressed in the OM of two double-mutant strains, one lacking
both OmpU and OmpT (
ompU2
ompT) and the
other lacking OmpT in a
toxR background
(
ompT
toxR). OmpT is the major OM protein
expressed in a
toxR strain, so again it is not surprising that its absence leads to expression of alternate OMPs to maintain structural integrity and/or permeability. Interestingly, the two ~35-kDa OMPs overexpressed in the double-mutant strains appear to be
two different OM proteins. An ~35-kDa OMP has been identified in
V. cholerae that shares antigenic epitopes with OmpA of
E. coli (2), but it remains to be determined
whether one of the ~35-kDa OMPs represents OmpA or some other porin
or protein.
The type II EPS pathway of V. cholerae is required for
secretion of CT and other factors, as well as insertion of OmpU and OmpT into the OM (47). Sandkvist et al. suggested that the
growth defect of an eps strain might be related to a lack of
OmpU and OmpT in the OM, causing a destabilizing effect on OM
integrity. However, our results have demonstrated that strains lacking
OmpU in the OM grow similar to the wild type. Notably, deletion of ompU (
ompU2) in an epsE strain
significantly increases the growth rate of this strain, suggesting that
the presence of non-OM localized OmpU in a strain lacking a functional
EPS leads to the reported growth defect. In other words, it is
apparently not the absence of OmpU in the OM but rather the presence of
OmpU within the cell that contributes to the growth defect of an
eps strain. It is therefore tempting to speculate that the
growth defect associated with the
ompU1 deletion is
likewise related to the presence of OmpU polypeptide not localized to
the OM. Still, the
ompU2 epsE strain does not demonstrate
a wild-type growth rate and maintains the filamentous cellular
morphology previously noted for the epsE strain
(47). Clearly, the presence of non-OM localized OmpU is
only partially responsible for the multiple phenotypes associated with
eps mutations. Notably, both the
ompU2 epsE
and the epsE strains synthesized flagella and were motile,
in contrast to what was recently reported (1).
Our studies have previously demonstrated that V. cholerae
strains expressing OmpU are more resistant to bile salts and other anionic detergents, and strains expressing OmpT are less resistant (42, 43). Consistent with our hypothesis that OmpU plays a protective role in enhanced bile resistance, the strain lacking OmpU
(
ompU2) was markedly more sensitive to the bile salt DOC than the wild-type strain. Our present data also support a negative role for OmpT in bile resistance because the
ompT strain
was more resistant to high concentrations of DOC than the wild-type strain. Interestingly, a strain lacking both OmpU and OmpT
(
ompU2
ompT) displayed levels of DOC
resistance similar to that of the wild type.
toxR+ strains express little OmpT under
laboratory conditions, but apparently this low level of expression is
sufficient to render the
ompU2 strain more sensitive to
DOC than a
ompU2
ompT strain and to render
a wild-type strain more sensitive than a
ompT strain.
Our findings corroborate the overall hypothesis that the relationship between OmpU and OmpT of V. cholerae is similar to that postulated to exist between OmpC and OmpF in serovar Typhimurium. Like other intestinal bacteria (37), V. cholerae must persist in an environment that is full of bile salts, where porin properties are ideal for excluding these large, negatively charged hydrophobic compounds. In serovar Typhimurium, OmpC, which has a small pore size and is more cationic selective than OmpF, is less permeable to bile salts and is predicted to be preferentially expressed within the intestinal environment. On the other hand, in nutrient-poor, low-osmolarity environments, such as in ponds and streams, OmpF, which has a larger pore size and is less cationic selective (and more permeable to bile) than OmpC, is presumed to be preferentially expressed (37). We hypothesize an analogous scenario for V. cholerae, with the expression of OmpU being preferred within the intestine and OmpT being preferentially expressed within the aquatic environment. Although OmpU has been reported previously to have a larger pore size than OmpT utilizing carbohydrate solutes (7), this does not necessarily reflect the relative permeabilities of these porins toward anionic detergents. Studies aimed at determining the relative ionic specificities for OmpU and OmpT are in progress.
Strains lacking either OmpU or OmpT or both expressed and secreted
wild-type levels of CT and produced wild-type levels of TCP under
laboratory inducing conditions, indicating that the lack of either
porin does not adversely affect the ToxR/TcpP/ToxT virulence signaling
cascade. However, we have recently shown that expression of OmpT in
place of OmpU negatively affects the virulence cascade at the level of
toxT transcription (42). These results are
consistent with a negative role for OmpT, but the lack of a positive
role for either OmpU or OmpT, in virulence factor expression. However,
in contrast to the strain truly lacking OmpU (
ompU2), a
strain with the
ompU1 mutation had a defect in CT and TCP
production under laboratory inducing conditions. This mutation confers
a dominant-negative effect similar to those conferred by mutations in
the EPS apparatus (see above), but its defect in expression of
extracellular CT could not be attributed to lack of secretion. It is
therefore conceivable that the
ompU1 mutation affects the ToxR/TcpP/ToxT signaling cascade, either indirectly by altering growth
or directly by interfering with inducing signals.
Deep-rough serovar Typhimurium mutants have been described as having
drastically less porins in the OM compared to the wild type
(3), which leads to increased phospholipid in the OM and rapid transmembrane diffusion of lipophilic solutes like bile and
contributing to instability of the OM (38). We were unable to identify any similar perturbations to the integrity of the OM of
V. cholerae omp mutants by several criteria. None of the ompU and/or ompT deletion strains displayed any
increase in serum or polymyxin B sensitivity, leakage of
-lactamase
from the periplasm, or structural abnormality in the LPS, indicating
that the lack of OmpU and/or OmpT in the OM does not result in a
defective OM or abnormal LPS.
OmpU has been hypothesized to serve as an adhesin during V. cholerae intestinal colonization (50). Due to
difficulties in obtaining ompU mutations, however, the
previous studies were not performed in strains lacking OmpU. Our
experiments with porin-deficient strains demonstrate that neither OmpU
nor OmpT are essential for colonization of the mouse small intestine.
The mild colonization defect associated with the
ompU2
strain (<10-fold) may be attributed to an inability of this strain to
compete with the wild type in regard to ultimate growth yield, because
a similar competitive defect was seen during growth in vitro. The
ompU2 strain was noticeably more sensitive to DOC than
was the wild type, and therefore we expected that it would be defective
for colonization in the presence of bile salts within the intestine.
However, it colonized similarly to the double-mutant
ompU2
ompT strain, which has levels of bile
resistance similar to those of the wild type. It appears that
OmpU-dependent bile resistance is not a critical factor in colonization
of the infant mouse intestine. This may not be an ideal model to study
the interaction between the pathogens and the anionic detergents in vivo.
Our previous study demonstrated that a strain expressing OmpT in place of OmpU is significantly reduced for intestinal colonization (>100-fold); in combination with the experiments presented here, it is clear that this colonization defect is due to the presence of OmpT rather than the absence of OmpU. One hypothesis that accounts for this observation is that the presence of OmpT in the OM alters the flux of signaling molecules into the periplasm, thus reducing the expression of TCP and other colonization factors via the ToxR/TcpP/ToxT virulence cascade. This could be corroborated in vitro, because a strain expressing OmpT in place of OmpU expresses considerably less CT and TCP under laboratory inducing conditions. As shown here, strains lacking either OmpU and/or OmpT express CT and TCP in a way similar to that of wild type in vitro and colonize similar to the wild type in vivo. Taken together, this suggests that the most important role for ToxR in porin modulation during colonization is the repression of ompT rather than the activation of ompU. However, it should be noted that the current studies were performed in V. cholerae strains of the classical biotype. Because the classical and El Tor biotypes differ significantly in the laboratory conditions that induce CT and TCP expression, ompU and ompT mutations may have different effects on the virulence cascade in the two biotypes.
| |
ACKNOWLEDGMENTS |
|---|
We thank J. Peterson for his generous gift of antisera to
V. cholerae OM proteins, S. Sozhamannan for providing
plasmids pAA35 and pAA48, C. Lopez-Macias for plasmid pJS752-3, M. Waldor for CTX
-Kan, and J. Nesper for assistance with the LPS analysis.
This study was supported by an institutional new faculty award of the Howard Hughes Medical Institute to K.E.K. and National Institutes of Health Microbial Pathogenesis training grant AI07271-15 to D.P.
| |
FOOTNOTES |
|---|
* Corresponding author. Mailing address: Department of Microbiology, University of Texas Health Science Center, 7703 Floyd Curl Dr., San Antonio, TX 78229-3900. Phone: (210) 567-3990. Fax: (210) 567-9231. E-mail: klose{at}uthscsa.edu.
Present address: Department of Microbiology and Molecular Genetics,
Harvard Medical School, Boston, MA 02115.
| |
REFERENCES |
|---|
|
|
|---|
| 1. |
Ali, A.,
J. A. Johnson,
A. A. Franco,
D. J. Metzger,
T. D. Connell,
J. G. Morris, Jr., and S. Sozhamannan.
2000.
Mutations in the extracellular protein secretion pathway genes (EPS) interfere with rugose polysaccharide production in and motility of Vibrio cholerae.
Infect. Immun.
68:1967-1974 |
| 2. | Alm, R., G. Braun, R. Morona, and P. Manning. 1986. Detection of an OmpA-like protein in Vibrio cholerae. FEMS Microbiol. Lett. 37:99-104[CrossRef]. |
| 3. |
Ames, G. F.,
E. N. Spudich, and H. Nikaido.
1974.
Protein composition of the outer membrane of Salmonella typhimurium: effect of lipopolysaccharide mutations.
J. Bacteriol.
117:406-416 |
| 4. | Benz, R., E. Maier, and T. Chakraborty. 1997. Purification of OmpU from Vibrio cholerae classical strain 569B: evidence for the formation of large cation-selective ion-permeable channels by OmpU. Microbiologia 13:321-330[Medline]. |
| 5. | Benz, R., A. Schmid, P. Van der Ley, and J. Tommassen. 1989. Molecular basis of porin selectivity: membrane experiments with OmpC-PhoE and OmpF-PhoE hybrid proteins of Escherichia coli K-12. Biochim. Biophys. Acta 981:8-14[Medline]. |
| 6. |
Bernardini, M. L.,
M. G. Sanna,
A. Fontaine, and P. J. Sansonetti.
1993.
OmpC is involved in invasion of epithelial cells by Shigella flexneri.
Infect. Immun.
61:3625-3635 |
| 7. |
Chakrabarti, S. R.,
K. Chaudhuri,
K. Sen, and J. Das.
1996.
Porins of Vibrio cholerae: purification and characterization of OmpU.
J. Bacteriol.
178:524-530 |
| 8. | Champion, G. A., M. N. Neely, M. A. Brennan, and V. J. DiRita. 1997. A branch in the ToxR regulatory cascade of Vibrio cholerae revealed by characterization of toxT mutant strains. Mol. Microbiol. 23:323-331[CrossRef][Medline]. |
| 9. | Correa, N. E., C. M. Lauriano, R. McGee, and K. E. Klose. 2000. Phosphorylation of the flagellar regulatory protein FlrC is necessary for Vibrio cholerae motility and enhanced colonization. Mol. Microbiol. 35:743-755[CrossRef][Medline]. |
| 10. | Cowan, S. W., T. Schirmer, G. Rummel, M. Steiert, R. Ghosh, R. A. Pauptit, J. N. Jansonius, and J. P. Rosenbusch. 1992. Crystal structures explain functional properties of two E. coli porins. Nature 358:727-733[CrossRef][Medline]. |
| 11. | Crawford, J. A., J. B. Kaper, and V. J. DiRita. 1998. Analysis of ToxR-dependent transcription activation of ompU, the gene encoding a major envelope protein in Vibrio cholerae. Mol. Microbiol. 29:235-246[CrossRef][Medline]. |
| 12. | Das, M., A. K. Chopra, J. M. Cantu, and J. W. Peterson. 1998. Antisera to selected outer membrane proteins of Vibrio cholerae protect against challenge with homologous and heterologous strains of V. cholerae. FEMS Immunol. Med. Microbiol. 22:303-308[CrossRef][Medline]. |
| 13. |
DiRita, V. J.,
M. Neely,
R. K. Taylor, and P. M. Bruss.
1996.
Differential expression of the ToxR regulon in classical and El Tor biotypes of Vibrio cholerae is due to biotype-specific control over toxT expression.
Proc. Natl. Acad. Sci. USA
93:7991-7995 |
| 14. |
DiRita, V. J.,
C. Parsot,
G. Jander, and J. J. Mekalanos.
1991.
Regulatory cascade controls virulence in Vibrio cholerae.
Proc. Natl. Acad. Sci. USA
88:5403-5407 |
| 15. |
Donnenberg, M. S., and J. B. Kaper.
1991.
Construction of an eae deletion mutant of enteropathogenic Escherichia coli by using a positive-selection suicide vector.
Infect. Immun.
59:4310-4317 |
| 16. | Gardel, C. L., and J. J. Mekalanos. 1996. Alterations in Vibrio cholerae motility phenotypes correlate with changes in virulence factor expression. Infect. Immun. 64:2246-2255[Abstract]. |
| 17. | Hanahan, D. 1983. Studies on transformation of Escherichia coli with plasmids. J. Mol. Biol. 166:577-580. |
| 18. |
Hase, C. C., and J. J. Mekalanos.
1998.
TcpP protein is a positive regulator of virulence gene expression in Vibrio cholerae.
Proc. Natl. Acad. Sci. USA
95:730-734 |
| 19. | Heidelberg, J. F., J. A. Eisen, W. C. Nelson, R. A. Clayton, M. L. Gwinn, R. J. Dodson, D. H. Haft, E. K. Hickey, J. D. Peterson, L. Umayam, S. R. Gill, K. E. Nelson, T. D. Read, H. Tettelin, D. Richardson, M. D. Ermolaeva, J. Vamathevan, S. Bass, H. Qin, I. Dragoi, P. Sellers, L. McDonald, T. Utterback, R. D. Fleishmann, W. C. Nierman, and O. White. 2000. DNA sequence of both chromosomes of the cholera pathogen Vibrio cholerae. Nature 406:477-483[CrossRef][Medline]. |
| 20. | Higgins, D. E., and V. J. DiRita. 1994. Transcriptional control of toxT, a regulatory gene in the ToxR regulon of Vibrio cholerae. Mol. Microbiol. 14:17-29[Medline]. |
| 21. |
Karaolis, D. K.,
J. A. Johnson,
C. C. Bailey,
E. C. Boedeker,
J. B. Kaper, and P. R. Reeves.
1998.
A Vibrio cholerae pathogenicity island associated with epidemic and pandemic strains.
Proc. Natl. Acad. Sci. USA
95:3134-3139 |
| 22. |
Kelley, J. T., and C. D. Parker.
1981.
Identification and preliminary characterization of Vibrio cholerae outer membrane proteins.
J. Bacteriol.
145:1018-1024 |
| 23. |
Kim, Y. B.,
J. Okuda,
C. Matsumoto,
N. Takahashi,
S. Hashimoto, and M. Nishibuchi.
1999.
Identification of Vibrio parahaemolyticus strains at the species level by PCR targeted to the toxR gene.
J. Clin. Microbiol.
37:1173-1177 |
| 24. | Klose, K. E., and J. J. Mekalanos. 1998. Differential regulation of multiple flagellins in Vibrio |